CAS NO: | 946414-98-8 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
生物活性 | Eldelumab (BMS-936557) is a humanised anti-CXCL10 (IP-10)monoclonal antibody (IgG1 type). Eldelumab selectively binds toCXCL10and blocksCXCL10-induced calcium flux and cell migration. Eldelumab can be used in studies of autoimmune and auto-inflammatory diseases such as rheumatoid arthritis, ulcerative colitis and crohn's disease[1][2]. |
IC50& Target | CXCL10 (IP-10)[1][2]. |
Clinical Trial | |
性状 | Liquid |
CAS 号 | 946414-98-8 |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |